LifeSci Venture Partners — Full Portfolio
6 tracked investments · listed companies and verified rows first
Erasca is a clinical-stage oncology company developing therapies targeting RAS- and MAPK pathway-driven cancers using a modality-agnostic approach including small molecules, large molecules, and protein degraders.
BiotechDeep TechDigital HealthMedical DevicesSan Diego, US
Pratik S. Multani, M.D.(Director)Valerie Harding-Start(Director)Jonathan E. Lim, M.D.(President and Executive Chairman)Gary Yeung, CFA(Chief Business Officer)Alexander W. Casdin(Director)James A. Bristol, Ph.D.(Director)
BiotechTel Aviv
Shmuel Cabilly(Director)June Almenoff(Executive Officer)Ofer Tsimchi(Director)Rick D Scruggs(Executive Officer, Director)Nicolas Weinstein(Director)Alla Felder(Director)
PartnerPaul Yook· solo GP
Windsor, US
Chris Camarsh(Director)James P. Linton(Executive Officer, Director)Marc-Francois Pelletier(Executive Officer, Director)Paul Predki(Executive Officer, Director)Stephanie Ann George(Executive Officer)
Board seatPaul Yook· per SEC Form D · $6M raise · filed Nov 2021
Company whose formation and launch the LifeSci team supported.
BiotechHealthtechSummit, US
Jouko Isojarvi(Executive Officer)Stephen D. Collins(Director)Gregory Mayes(Executive Officer, Director, Promoter)Heath Lukatch(Director)Warren Lammert(Director)Orrin Devinsky(Director)
PartnerPaul Yook· solo GP
BiotechPittsburgh, US
Raymond K. Houck(President, Chief Executive Officer and Director of Issuer)Lalit Chordia(Director)Mazen Hanna(Chief Scientific Officer)Ira Kalfus(Chief Medical Officer of Issuer)Philip Sussman(Director)Robert Roy(Director)
PartnerPaul Yook· solo GP
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.